{"title": "Homeopathic Vaccine Trial - Full Text View - ClinicalTrials.gov", "author": null, "url": "https://clinicaltrials.gov/ct2/show/NCT02825368", "hostname": "clinicaltrials.gov", "description": "Homeopathic Vaccine Trial - Full Text View.", "sitename": "ClinicalTrials.gov", "date": "2016-07-07", "cleaned_text": "| The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our | |ClinicalTrials.gov Identifier: NCT02825368| | | Recruitment Status : Unknown Verified August 2017 by McMaster University. Recruitment status was: Recruiting First Posted : July 7, 2016 Last Update Posted : August 4, 2017 - Study Details [Tabular View](/ct2/show/record/NCT02825368) [No Biological: Biological: Sugar Comparator: Control group || Other: Sterile saline | 0.5 mL, intramuscular Other: Sugar pellets - Antibody levels for diphtheria [ Time Frame: 3 weeks ] - Antibody levels for pertussis [ Time Frame: 3 weeks ] - Antibody levels for tetanus [ Time Frame: 3 weeks ] - Antibody levels for mumps [ Time Frame: 3 weeks ] - Antibody levels for measles [ Time Frame: 3 weeks ] Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, [Learn About Clinical Studies.](/ct2/about-studies/learn) |Ages Eligible for Study:||18 Years to Years Eligible for Study:||All| |Accepts Healthy Volunteers:||Yes| Inclusion Criteria: - Between the ages of 18 and 24 years - Has received primary childhood DTaP and MMR vaccinations - Available for a follow up visit (3 weeks after initial visit) Exclusion Criteria: - Received a live vaccine in the past 4 weeks - Has had a serious allergic reaction to a previous vaccination - Has allergies to one or more of the components of the vaccines to be used (Neomycin, egg protein) - Has a history of encephalopathy within 7 days of receiving DTP/DTap - Has received nosodes for Diphtheria, Tetanus, Pertussis, Measles and Mumps - Has received an adult booster dose of conventional vaccines of diphtheria, pertussis, tetanus, mumps, and measles (Tdap or MMR) - Has received immunosuppressive doses of steroids or anti-cancer drugs in the past 3 months - Is pregnant or if there is a chance they could become pregnant during the next month - Has a moderate to severe acute illness at the time of enrolment - Has cancer, leukemia, HIV/AIDS, or any other serious immune health condition - Has a history of Guillaume Barre Syndrome - Has received blood transfusion, blood products, or immune globulin within the past year To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT | "}